
Behind the Novavax vaccine trial: UK recruits welcome results
The Novavax vaccine has been found to be 89.3% effective at preventing COVID-19. Stockport NHS Foundation Trust in the UK recruited 762 participants, and was the second largest contributor to the study in the UK. Dr David Baxter, Principal Investigator for the trial at Stockport NHS Foundation Trust, said: “We… Read More















